FDA Approves Unknown Drug — APOTEX

# FDA Approves Apotex Generic Drug Application Apotex received FDA approval for ANDA210456 on April 21, 2026, marking another addition to the Canadian manufacturer's generic portfolio and potentially expanding competitive pricing options in the U.S. pharmaceutical market. The approval could intensify price competition in its respective therapeutic category while strengthening Apotex's position among leading generic drug suppliers.